Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
25.75
-1.33 (-4.91%)
At close: Jul 13, 2026, 4:00 PM EDT
25.92
+0.17 (0.67%)
After-hours: Jul 13, 2026, 7:33 PM EDT

Legend Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4,9814,0215,97610,9468,2407,189
Market Cap Growth
-19.15%-32.72%-45.40%32.83%14.63%91.93%
Enterprise Value
4,5363,1674,9039,6847,2386,309
Last Close Price
25.7521.7432.5460.1749.9246.61
Forward PE
33.88150.43----
PS Ratio
4.373.919.5338.3970.43104.45
PB Ratio
4.944.015.748.7511.079.39
P/TBV Ratio
4.914.005.728.4910.728.62
EV/Sales Ratio
3.983.087.8233.9761.8691.66
Debt / Equity Ratio
0.120.090.040.040.030.00
Net Debt / Equity Ratio
-0.73-0.85-1.03-1.01-1.35-1.15
Net Debt / EBITDA Ratio
7.727.943.732.482.412.24
Net Debt / FCF Ratio
6.146.636.793.054.513.66
Asset Turnover
0.680.600.360.180.100.07
Inventory Turnover
14.8414.6010.839.6810.800
Quick Ratio
1.641.514.076.513.444.07
Current Ratio
2.131.964.626.923.694.14
Return on Equity (ROE)
-24.27%-29.06%-15.45%-51.94%-59.11%-59.19%
Return on Assets (ROA)
-7.99%-8.42%-19.69%-33.10%-35.55%-43.73%
Return on Invested Capital (ROIC)
-65.74%-248.24%----
Return on Capital Employed (ROCE)
-12.05%-10.96%-20.46%-39.63%-45.22%-54.29%
Buyback Yield / Dilution
-0.75%-0.80%-3.84%-10.71%-12.91%-19.21%
Total Shareholder Return
-0.75%-0.80%-3.84%-10.71%-12.91%-19.21%
SEC Filings: 10-K · 10-Q